Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Generation Bio Co. (GBIO)

Compare
0.3975
+0.0273
+(7.37%)
At close: April 3 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
19,892
19,892
5,904
--
--
Operating Expense
99,085
99,085
144,467
141,182
119,101
Operating Income
-79,193
-79,193
-138,563
-141,182
-119,101
Net Non Operating Interest Income Expense
10,722
10,722
11,951
4,543
-50
Other Income Expense
-63,197
-63,197
--
--
--
Pretax Income
-131,668
-131,668
-126,612
-136,639
-119,151
Net Income Common Stockholders
-131,668
-131,668
-126,612
-136,639
-119,151
Diluted NI Available to Com Stockholders
-131,668
-131,668
-126,612
-136,639
-119,151
Basic EPS
-2.19
-1.98
-1.96
-2.35
-2.12
Diluted EPS
-2.19
-1.98
-1.96
-2.35
-2.12
Basic Average Shares
66,446.1340
66,624.2490
64,483.5200
58,114.8930
56,295.4090
Diluted Average Shares
66,446.1340
66,624.2490
64,483.5200
58,114.8930
56,295.4090
Total Operating Income as Reported
-142,390
-142,390
-138,563
-141,182
-119,101
Total Expenses
99,085
99,085
144,467
141,182
119,101
Net Income from Continuing & Discontinued Operation
-131,668
-131,668
-126,612
-136,639
-119,151
Normalized Income
-68,471
-68,471
-126,612
-136,639
-119,151
Interest Income
10,722
10,722
11,951
4,543
--
Interest Expense
--
--
--
--
50
Net Interest Income
10,722
10,722
11,951
4,543
-50
EBIT
-79,193
-79,193
-138,563
-141,182
-119,101
EBITDA
-74,262
-74,262
-133,300
-136,052
-114,569
Reconciled Depreciation
4,931
4,931
5,263
5,130
4,532
Net Income from Continuing Operation Net Minority Interest
-131,668
-131,668
-126,612
-136,639
-119,151
Total Unusual Items Excluding Goodwill
-63,197
-63,197
--
--
--
Total Unusual Items
-63,197
-63,197
--
--
--
Normalized EBITDA
-11,065
-11,065
-133,300
-136,052
-114,569
12/31/2021 - 6/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALXO ALX Oncology Holdings Inc.
0.5331
-10.48%
 
PMVP PMV Pharmaceuticals, Inc.
0.9950
-0.50%
 
ZNTL Zentalis Pharmaceuticals, Inc.
1.2850
-5.17%
 
STOK Stoke Therapeutics, Inc.
6.30
-4.55%
 
IPSC Century Therapeutics, Inc.
0.4590
-2.28%
 
VTYX Ventyx Biosciences, Inc.
1.0000
-5.66%
 
IGMS IGM Biosciences, Inc.
1.1600
-5.69%
 
FDMT 4D Molecular Therapeutics, Inc.
2.8850
-12.04%
 
ADVM Adverum Biotechnologies, Inc.
3.9400
-7.51%
 
KROS Keros Therapeutics, Inc.
10.28
+2.39%